The Greater Houston Partnership hosted its annual economic outlook event online — here's what the numbers indicate for Houston business in the new year. Photo via Getty Images

As much of the world is ready to celebrate a new year — one likely to be drastically less affected by COVID-19 — the Greater Houston Partnership released an annual report about what Houston's economy will look like in 2021.

Senior vice president of research Patrick Jankowski and his team put the Houston Region Economic Outlook report together and shared some its highlights at a virtual event hosted by Bob Harvey, president and CEO of GHP.

Of course, much of the study focused on how the coronavirus — as well as the impending vaccine — will affect the region's economy.

"At this point last year, neither Patrick nor any of us could have predicted the arrival of COVID-19 and its devastating impact on the global economy," Harvey says at the event. "Here in Houston COVID wreaked havoc on industries across the spectrum from energy to hospitality."

In the early weeks, the Houston region lost 350,000 jobs, according to the report, and in the months since, the region added back about half with 176,000 jobs.

Below are some more key takeaways from the report — and in most cases, the outcome depends on how COVID-19 case numbers are affected by the holidays and the accessibility of the vaccine.

"The weeks and months ahead are likely to be some of the most difficult of the pandemic," Harvey cautions. "We cannot afford to let our guard down now as we approach the finish line."

Energy will continue to struggle

Photo via Getty Images

The past six years have been rough for oil and gas, and in Houston specifically, Houston has lost nearly 100,000 upstream energy jobs, and the energy industry's share of Houston's GDP has fallen from 35 to 40 percent (a GHP '14 estimate) to 20 to 25 percent (a GHP '19 estimate).

The Russia-Saudi Oil Feud in March brought this decline to its head and it's not looking like it's getting back to normal any time soon. "Next year won't be any easier for the industry. While global demand has improved, it will remain three to five million barrels per day below pre-COVID levels," reads the report.

The new administration is expected to have several goals that will affect the industry, such as bringing the U.S. back into the Paris Agreement, negotiating new mileage and emission rules for autos and trucks, slowing or halting oil leasing on federal lands and in the Gulf of Mexico, increasing environmental scrutiny during the pipeline permitting process, and more.

Jobs in some industries will come back

Chart via GHP

According to the report, Houston's unemployment rate, at 3.9 percent in February, jumped to 5.5 percent in March, then 14.3 percent in April — the highest on record.

"Unemployment has improved — we're at 7.9 percent now," Jankowski says at the event.

But recovery depends on the industry. Jankowski predicts that retail and energy are both expected to continue to lose jobs, and other industry sectors — such as government, arts and entertainment, and educational services — aren't expected to grow by much.

However, some of the sectors hardest hit in 2020 — construction, manufacturing, support services, and restaurants — are expected to bounce back with thousands of new jobs.

The chart gives a range of job growth — there's a lower and a higher outlook. Jankowski says it depends on how well the vaccine is doing.

If by mid-year, we don't have much of the population inoculated, it's going to be closer to that lower number," he says.

2021 will be a "bipolar year"

Patrick Jankowski of the GHP. Photo via Houston.org

The first and second halves of the year are going to look different, Jankowski says, it's just a matter of how different at this point. In addition to the vaccine and COVID case numbers, the things the GHP as well as Houston businesses are watching is the new Biden Administration

"We won't see any significant growth in the economy until we get to the second half of the year," he says

The first quarter of 2021 will be especially tough for Houston, according to the report, since the region always experiences job losses in January as retail, restaurant, and transportation workers hired for the holiday season are rolled off. Additionally, contract workers employed to meet year-end deadlines are released and plans for reorganization are implemented.

"No one should be surprised when Houston loses 40,000 or more jobs this January," the report reads. "Houston's recovery will likely lag the U.S.'s by a few months, but growth will resume in the second half of '21."

Three panelists representing the real estate, banking, and health care industries weighed in on innovation in Houston. Photo via Greater Houston Partnership/Facebook

Overheard: Houston execs weigh in on the innovation ecosystem and local startups

Eavesdropping in Houston

Something has shifted in Houston, and businesses across industries — whether it be real estate, health care, or energy — are focused on innovation, emerging technologies, and the role of startups within the business community.

At the Greater Houston Partnership's annual Economic Outlook on December 5, three panelists from various industries gathered to discuss some of the biggest issues in Houston — from the multifamily real estate market to what the local workforce needs. The panel was moderated by Eddie Robinson, the morning news anchor for Houston Public Radio, and the panelists did weigh in a few issues affecting innovation.

Missed the talk? Here are a few overheard moments from the discussion.

"Houston allows you to do what you do. And you don't get that in other places."

Photo via Greater Houston Partnership/Facebook

Bradley R. Freels, chairman of Midway Cos. Freels says, while the city's been overshadowed by other Texas cities for innovation and tech — and even by its large oil and gas industry presence, the city is becoming a great place for startups. "This is a great place to do business because it's easy to get started in business here. I think it's just over shadowed to some degree," he says, adding later that, "the initiative around the innovation corridor is real."

"Houston is unique, in my opinion, in how open and welcoming it is."

Photo via Greater Houston Partnership/Facebook

— David Milich, CEO of UnitedHealthcare - Texas & Oklahoma. Building off the panelists point that Houston is a spirited, can-do city, Milich specifies that it's the collaboration between people in Houston that sets the city apart. "When we present ourselves with something to get done, we generally get it down."

"We're realizing that the economy is shifting. As we move forward in the 21st century, our entire workforce needs to be tech fluent."

Photo via Greater Houston Partnership/Facebook

Nataly Marks, managing director and region manager at JPMorgan Chase. When asked about jobs needed in Houston, Marks specified technology positions. Moreover, JPMorgan Chase is emphasizing getting the entire staff proficient in the latest tech resources.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Nominations are now open for the 2025 Houston Innovation Awards

Calling All Innovators

Calling all Houston innovators: The Houston Innovation Awards return this fall to celebrate the best and brightest in the Houston innovation ecosystem right now.

Presented by InnovationMap, the fifth annual Houston Innovation Awards will take place November 5 at TMC Helix Park.

The awards program will honor the top startups and innovators in Houston across 10 categories, and we're asking you to nominate the most deserving Houston innovators and innovative companies today.

This year's categories are:

  • Minority-founded Business, honoring an innovative startup founded or co-founded by BIPOC or LGBTQ+ representation.
  • Female-founded Business, honoring an innovative startup founded or co-founded by a woman.
  • Energy Transition Business, honoring an innovative startup providing a solution within renewables, climatetech, clean energy, alternative materials, circular economy, and beyond.
  • Health Tech Business, honoring an innovative startup within the health and medical technology sectors.
  • Deep Tech Business, honoring an innovative startup providing technology solutions based on substantial scientific or engineering challenges, including those in the AI, robotics, and space sectors.
  • Startup of the Year (People's Choice), honoring a startup celebrating a recent milestone or success. The winner will be selected by the community via an interactive voting experience.
  • Scaleup of the Year, honoring an innovative later-stage startup that's recently reached a significant milestone in company growth.
  • Incubator/Accelerator of the Year, honoring a local incubator or accelerator that is championing and fueling the growth of Houston startups.
  • Mentor of the Year, honoring an individual who dedicates their time and expertise to guide and support budding entrepreneurs.
  • Trailblazer, honoring an innovator who's made a lasting impact on the Houston innovation community.

Nominations may be made on behalf of yourself, your organization, and other leaders in the local innovation scene. The nomination period closes on August 31, so don't delay — nominate today at this link, or fill out the embedded form below.

Our panel of esteemed judges will review the nominations, and determine the finalists and winners. Finalists will be unveiled on September 30, and the 2025 Houston Innovation Awards winners will be announced live at our event on November 5.

Tickets will go on sale this fall. Stay tuned for that announcement, as well as more fanfare leading up to the 2025 Houston Innovation Awards.

Nominate now:

Interested in Innovation Awards sponsorship opportunities? Please contact sales@innovationmap.com.

MD Anderson launches $10M collaboration to advance personalized cancer treatment tech

fighting cancer

The University of Texas MD Anderson Cancer Center and Japan’s TOPPAN Holdings Inc. have announced a strategic collaboration to co-develop TOPPAN Holdings’ 3D cell culture, or organoid, technology known as invivoid.

The technology will be used as a tool for personalized cancer treatments and drug screening efforts, according to a release from MD Anderson. TOPPAN has committed $10 million over five years to advance the joint research activities.

“The strategic alliance with MD Anderson paves a promising path toward personalized cancer medicine," Hiroshi Asada, head of the Business Innovation Center at TOPPAN Holdings, said in a news release.

Invivoid is capable of establishing organoid models directly from patient biopsies or other tissues in a way that is faster and more efficient. Researchers may be able to test a variety of potential treatments in the laboratory to understand which approach may work best for the patient, if validated clinically.

“Organoids allow us to model the three-dimensional complexity of human cancers in the lab, thus allowing us to engineer a powerful translational engine—one that could not only predict how patients will respond to therapy before treatment begins but also could help to reimagine how we discover and validate next-generation therapies," Dr. Donna Hansel, division head of pathology and laboratory medicine at MD Anderson, added in the news release. “Through this collaboration, we hope to make meaningful progress in modeling cancer biology for therapeutic innovation.”

The collaboration will build upon preclinical research previously conducted by MD Anderson and TOPPAN. The organizations will work collaboratively to obtain College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments (CLIA) certifications for the technology, which demonstrate a commitment to high-quality patient care. Once the certifications are obtained, they plan to conduct observational clinical studies and then prospective clinical studies.

“We believe our proprietary invivoid 3D cell culture technology, by enabling the rapid establishment of organoid models directly from patient biopsies, has strong potential to help identify more effective treatment options and reduce the likelihood of unnecessary therapies,” Asada added in the release. “Through collaboration on CAP/CLIA certification and clinical validation, we aim to bring this innovation closer to real-world patient care and contribute meaningfully to the advancement of cancer medicine."